We use cookies for a better user experience. Read our Privacy Policy
I AgreeTolerase G is a proline-specific digestive enzyme that is specially designed to help digest the complex gluten protein. It is so far the first and only enzyme that has shown to be more effective for humans. Tolerase G is effective for both low, as well as high-caloric meals. Tolerase G is targeted towards gluten-intolerant consumers, that are already following a gluten-friendly diet but require more additional enzymes to breakdown gluten. It is widely available in powdered as well as in capsule form for consumers. Tolerase G is used in the nutraceutical industries for offering it as a dietary supplement for consumers.
The rising health consciousness among the consumers is expected to drive the market growth. Tolerase G is vegan friendly that can be offered to consumers looking for vegan dietary supplements and can be used for producing vegan functional food products.
The rising number of Celiac Patients to Drive Market Growth for Tolerase G
Celiac disease is a disease that occurs in genetically predisposed consumers which leads to indigestion of gluten and damage to the small intestine. This disease is anticipated to affect 1 in 100 humans across the globe. Gluten consumption by celiac patients damages the villi, small finger-like projections that are present in the small intestine. These finger-like projections when damaged result in improper nutrients absorption in the body that can lead to long-term health problems. Tolerase G is a digestive enzyme that helps in the breakdown of gluten and reduces its effect on gluten-intolerant consumers. It is among the few effective solutions for celiac disease. With the rising number of gluten-intolerant consumers, Tolerase G market demand is expected to grow.
Some of the Tolerase G market players include DSM N.V., Bricker Labs, Swanson Health, Biogena Group, Douglas Laboratories, Agera Health, Silver Fern, Microbiome Labs UK Ltd, Clinicians Ltd, Pure Encapsulations, LLC, and others
Based on Form, the Global Tolerase G Market has been segmented as:
Based on End Use, the Global Tolerase G Market has been segmented as:
Based on Distribution Channel, the Global Tolerase G Market has been segmented as:
Based on Region, the Global Tolerase G Market has been segmented as:
Tolerase G market is expected to grow over the forecast years owing to the high demand for functional food products and its growth in the nutraceutical industry. Tolerase G is used in the food and beverage industry producing food products for gluten intolerant consumers that offer opportunities for manufacturers. The increasing health consciousness among the consumers as well as willingness to pay a premium amount for functional food products is expected to benefit the Tolerase G manufacturers. The players in the Tolerase G market can offer it for various applications in the food and beverage industry that can fetch them the opportunity for high revenue growth.
Tolerase G is a digestive enzyme largely consumed in the North American market owing to the presence of a large number of health-conscious consumers. The penetration of the product is also growing in the European market with its increasing application in the food and beverage industry for producing functional food products. Asia Pacific market holds high potential for Tolerase G with the developing countries and fast urbanization in the region. Thus manufacturers are focusing on targeting the Asia Pacific market for earning more revenue and increase their market share in the global market.
The outbreak of COVID-19 has heavily impacted global business activities and manufacturing activities due to the lockdown imposed in various regions. This also affected the food and beverage industry with supply chain disruption impacting the fluctuation of demand and supply. The outbreak of COVID-19 also increased the demand for functional food products, thus nutraceutical industry seeing growth during the pandemic. Thus the global Tolerase G market is expected to see a low effect of pandemic over the next two to three quarters.
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
N/A
Complete the form below and we'll get back to you shortly.